Cours MiMedx Group Inc OTC Bulletin Board
Actions
Recherche biotechnologique et médicale
CA 2024 * | 361 M 330 M | CA 2025 * | 406 M 371 M | Capitalisation | 1,11 Md 1,01 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 45 M 41,07 M | Résultat net 2025 * | 55 M 50,2 M | VE / CA 2024 * | 3,07 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 2,73 x |
PER 2024 * |
24
x | PER 2025 * |
18,1
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 97,64% |
Dernier transcript sur MiMedx Group Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Joe Capper
CEO | Chief Executive Officer | 60 | 27/01/23 |
Douglas Rice
DFI | Director of Finance/CFO | 58 | 05/07/23 |
John R. Harper
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/21 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
William Hawkins
BRD | Director/Board Member | 70 | 02/07/20 |
Phyllis Gardner
BRD | Director/Board Member | 73 | 08/03/21 |
K. Newton
BRD | Director/Board Member | 61 | 19/06/19 |
Varia. 1 janv. | Capi. | |
---|---|---|
-25,17% | 122 M | |
-6,89% | 68,14 M | |
+1,08% | 58,18 M | |
+1,20% | 53,31 M |